Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Differential experimental micrometastasis to lung, liver, and bone with lacZ-tagged CWR22R prostate carcinoma cells.

Holleran JL, Miller CJ, Edgehouse NL, Pretlow TP, Culp LA.

Clin Exp Metastasis. 2002;19(1):17-24.

PMID:
11918079
2.

Prostate cancer and other xenografts from cells in peripheral blood of patients.

Pretlow TG, Schwartz S, Giaconia JM, Wright AL, Grimm HA, Edgehouse NL, Murphy JR, Markowitz SD, Jamison JM, Summers JL, Hamlin CR, MacLennan GT, Resnick MI, Pretlow TP, Connell CF.

Cancer Res. 2000 Aug 1;60(15):4033-6.

3.

Molecular cytogenetic studies of a serially transplanted primary prostatic carcinoma xenograft (CWR22) and four relapsed tumors.

Kochera M, Depinet TW, Pretlow TP, Giaconia JM, Edgehouse NL, Pretlow TG, Schwartz S.

Prostate. 1999 Sep 15;41(1):7-11.

PMID:
10440870
4.

CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar.

Nagabhushan M, Miller CM, Pretlow TP, Giaconia JM, Edgehouse NL, Schwartz S, Kung HJ, de Vere White RW, Gumerlock PH, Resnick MI, Amini SB, Pretlow TG.

Cancer Res. 1996 Jul 1;56(13):3042-6.

5.

CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma.

Wainstein MA, He F, Robinson D, Kung HJ, Schwartz S, Giaconia JM, Edgehouse NL, Pretlow TP, Bodner DR, Kursh ED, et al.

Cancer Res. 1994 Dec 1;54(23):6049-52.

6.

Ischemia-induced development of cerebral edema in awake and anesthetized gerbils.

Edgehouse NL, Dorman RV.

Neurochem Pathol. 1987 Oct;7(2):169-79.

PMID:
3447077

Supplemental Content

Loading ...
Support Center